What's new

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised

May 28, 2025 - 18:55
 0
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Endolymphatic Sac Decompression Effective for Vertigo, Migraine

Next Article

Human medicines European public assessment report (EPAR): NovoRapid, insulin asp...

Related Posts

Human medicines European public assessment report (EPAR): Artesunate Amivas, artesunate, Date of authorisation: 22/11/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0

Human medicines European public assessment report (EPAR): Maapliv, amino acids, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0